Zyntra Advisory SRL
Zyntra Advisory reported total assets of 22,045 € at the end of the 2025 financial year (annual accounts filed with the NBB on 27 Aug 2026).
The score of Zyntra Advisory shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Zyntra Advisory's annual accounts
| 2025 | |
|---|---|
| Net result | 12,342 € |
| Equity | 12,342 € |
| Cash | 22,045 € |
| EBITDA | 15,506 € |
| Total assets | 22,045 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 27 Aug 2026
Zyntra Advisory's financial analysis
- Solvency56.0%sector median: 45.7%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Zyntra Advisory
Zyntra Advisory's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1027.548.021
- VAT number
- BE1027548021
- Peppol
- Registered · 0208:1027548021 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 12 Sep 2025
- Registered office
- 1040 Etterbeek
- Latest accounts
- 2025 · filed on 27 Aug 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
Zyntra Advisory (SRL) has been based in Etterbeek since 2025, active in: research and experimental development on biotechnology. For 2025, it reports a net profit of 12,342 € and equity of 12,342 €; its revenue is not published. Its solvency stands at 56.0%, above the median of its sector (45.7%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Zyntra Advisory
Companies in the same business, of comparable size and area, outside its group.
- Nanogyre Research and experimental development on natural sciences and engineering Liège · balance sheet 22,232 €
- Turnacum Wholesale of pharmaceutical and medical goods Tournai · balance sheet 25,766 €
- RheADC Manufacture of basic pharmaceutical products Leuven · balance sheet 31,395 €
- Pharmelle Retail sale of pharmaceutical products Aalst · balance sheet 48,646 €
- OncoRNA Research and experimental development on natural sciences and engineering Charleroi · balance sheet 20,034 €
- 4K Services Belgium Research and experimental development on natural sciences and engineering Etterbeek · balance sheet 59,971 €
- AJD Services Research and experimental development on natural sciences and engineering Herve · balance sheet 61,086 €
- P & X Medical Research and experimental development on natural sciences and engineering Wevelgem · balance sheet 50,706 €
Frequently asked questions about Zyntra Advisory
What is the revenue of Zyntra Advisory?
Zyntra Advisory files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Zyntra Advisory?
In Belgium, the VAT number is the company number prefixed with BE: BE1027548021 for Zyntra Advisory, if the company is VAT-registered. Its company number (CBE) is 1027.548.021.
Where is the registered office of Zyntra Advisory?
According to the CBE register, the registered office of Zyntra Advisory is in 1040 Etterbeek.
What is the equity of Zyntra Advisory?
At the close of the 2025 financial year, the equity of Zyntra Advisory amounts to 12,342 €, a solvency of 56.0% of total assets.
Who manages Zyntra Advisory?
The register lists 1 active mandates at Zyntra Advisory. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Zyntra Advisory
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →